Stock Research: Merck (DE)

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Merck (DE)

XTRA:MRK DE0006599905
27
  • Value
    42
  • Growth
    1
  • Safety
    Safety
    93
  • Combined
    42
  • Sentiment
    25
  • 360° View
    360° View
    27
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Merck KGaA is a science and technology company. It operates in Healthcare, Life Sciences, and Electronics. The company operates in Germany, the United States, and Canada. In the last fiscal year, the company had a market cap of $55,221 million, profits of $13,021 million, and revenue of $21,903 million with 62557 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 27 (better than 27% compared with alternatives), overall professional sentiment and financial characteristics for the stock Merck (DE) are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Merck (DE). Only the consolidated Value Rank has an attractive rank of 93, which means that the share price of Merck (DE) is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 93% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 1, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 42, meaning the company has a riskier financing structure than 58% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 75% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 25. ...read more

more
Index
CDAX
DAX 40
Low Emissions
Employee Focus EU
Human Rights
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
93 82 85 70
Growth
1 10 1 89
Safety
Safety
42 57 44 6
Sentiment
25 64 24 44
360° View
360° View
27 57 16 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
54 78 75 43
Opinions Change
10 28 36 48
Pro Holdings
n/a 43 30 38
Market Pulse
68 79 25 63
Sentiment
25 64 24 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
93 82 85 70
Growth
1 10 1 89
Safety Safety
42 57 44 6
Combined
42 57 30 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
81 73 60 56
Price vs. Earnings (P/E)
67 51 93 91
Price vs. Book (P/B)
72 64 63 48
Dividend Yield
64 55 57 53
Value
93 82 85 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
21 37 18 53
Profit Growth
32 25 22 67
Capital Growth
6 20 28 68
Stock Returns
9 28 30 90
Growth
1 10 1 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
52 59 42 15
Refinancing
27 25 37 14
Liquidity
60 67 64 39
Safety Safety
42 57 44 6

Similar Stocks

Discover high‑ranked alternatives to Merck (DE) and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.